Plasminogen activator inhibitor I 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss

Clinical Chemistry

Volumn 49, Issue 7, 2003, Pages 1081-1086

  Dossenbach Glaninger, Astrid ^a   Van Trotsenburg, Michael ^b   Dossenbach, Martin ^c   Oberkanins, Christian ^d   Moritz, Anne ^d   Krugluger, Walter ^a   Huber, Johannes ^b   Hopmeier, Pierre ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c ELI LILLY AND COMPANY   (United States)

^d VIENNALAB DIAGNOSTICS GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; PARITY; RISK ASSESSMENT; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; FACTOR XIII; FEMALE; FIBRINOLYSIS; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY;

EID: 0037934711     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.7.1081     Document Type: Article

References (33)

1. Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999;82:634-40.
2. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
3. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost 1999;81:891-9.
4. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000;53:573-80.
5. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996;75:387-8.
6. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
7. Lockshin MD. Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost 1999;82:641-8.
8. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82:6-9.
9. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001;86:104-11.
10. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002;77:342-7.
11. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, et al. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000;49:845-52.
12. Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage. Fertil Steril 1999;72:765-74.
13. Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, et al. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Placenta 2000;21:184-93.
14. Sheppard BL, Bonnar J. Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb Hemost 1999;25:443-6.
15. Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, et al. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 2000;21:754-62.
16. Craven CM, Zhao L, Ward K. Lateral placental growth occurs by trophoblast cell invasion of decidual veins. Placenta 2000;21:160-9.
17. Craven CM, Chedwick LR, Ward K. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblast cell invasion. Am J Obstet Gynecol 2002;186:291-6.
18. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999;71:1048-53.
19. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000;96:988-95.
20. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, et al. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997;77:1096-103.
21. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993;122:606-15.
22. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, et al. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol 1997;17:2082-7.
23. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993;268:10739-45.
24. Anwar R, Gallivan L, Edmonds SD, Markham AF. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999;93:897-905.
25. Muszbek L. Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost 2000;84:524-7.
26. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-90.
27. Gris JC, Quere I, Sanmarco M, Boutiere B, Mercier E, Amiral J, et al. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA. Thromb Haemost 2000;84:228-36.
28. Oberkanins C, Moritz A, De Villiers JNP, Kotze MJ, Kury F. A reverse-hybridization assay for the rapid and simultaneous detection of nine HFE gene mutations. Genet Testing 2000;4:121-4.
29. Oberkanins C, Moritz A, Kury F. Reverse-hybridization analysis of multiple genetic risk factors for cardiovascular disease. [Abstract]. Thromb Haemost 2001;86(Suppl):OC8,63.
30. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44-8.
31. Unfried G, Griesmacher A, Weismuller W, Nagele F, Buber JC, Tempfer CB. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol 2002;99:614-9.
32. Sidelmann JJ, Gram J, Jespersen J, Kluft C. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost 2000;26:605-18.
33. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998;79:8-13.